VEGFA and age-related macular degeneration: In recent years, intravitreal injections of antibodies inhibiting vascular endothelium growth factor (VEGF, strongly expressed by Müller cells and involved in neovascularization) have been commonly used to treat CNV [1,44], due to its predominant role on cellular proliferation, migration, and angiogenesis in AMD.